SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Latest Comments
  • So simply put, we have the NABP saying that all ph... »
  • The original Brustle decision was widely criticise... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    Author Archive

    05/06/2014: People In IP: Shifting Sands In The Global IP Community
    25/02/2014: Year Ahead: Biotech, IP Promise to Create Controversy From Farms To Big Pharma In 2014
    07/02/2014: EPO Appeals Board Upholds Ruling Limiting Stem Cell Patentability
    10/12/2013: Crowdfunding ‘Operation Ninja STAR’ Arms Small Business Against Patent ‘Trolls’
    02/12/2013: People In IP: Movers And Shakers In The IP World Jostle For Influence
    22/11/2013: Goodlatte Patent Bill Heads To House; Trolls Not So Bad, After All?
    20/11/2013: Goodlatte Patent Troll Bill Being Marked Up; Patent Lawyers Say Let AIA Work
    27/09/2013: Big Pharmaceutical Firms Say MDGs Partnerships Are ‘Best-Kept Secret’
    16/10/2012: Standards-Setting Organisations Increasingly Make IPR A Priority
    27/09/2012: IP And The White House: What Happens With IP Issues After The US Presidential Election?
    13/09/2012: America Invents Act: Another Piece Of Patent Reform Puzzle Falls Into Place
    19/07/2012: IP Exchange ‘Getting Some Teeth’; First Offerings Likely In Autumn
    01/06/2012: US: New Battle Brewing At ITU Will ‘Determine The Future Of The Internet’
    11/05/2012: ICANN IP Advisory Group: Whois, Dot-Brands, Contracts Key Sticking Points In New Domains
    08/05/2012: INTA: Corporate Call To Action On New Domains, Social Media, Counterfeiting
    12/04/2012: US Government Report: IP Boon To US Economy, Accounts For 40 Million Jobs
    21/02/2012: Special Report: TPP Negotiations To Heat Up In Melbourne Over Patents, Copyright, Medicines
    23/01/2012: SOPA, Piracy, Pharmaceuticals May Dominate US IP Policy Discussions In 2012
    17/01/2012: All Eyes On US Stop Online Piracy Act (SOPA): Fate Of Bill Now Unclear
    20/12/2011: Special Report – US IP Attachés Report On Strategies Abroad
    08/12/2011: Patent Reform Has USPTO’s Trial And Appeal Board At The ‘Centre Of A Storm’
    06/12/2011: America Invents Act Forges Ahead; Concerns Remain About First-To-File, Other Provisions
    02/11/2011: USPTO, Small Businesses Talk Patent Reform, Harmonisation, Fee Diversion
    09/09/2011: Patent Reform Passes US Senate, Makes History; Obama to Sign: IP-Watch Analysis Shows Who Wins
    07/09/2011: Senate Takes Up Patent Reform; Chairman Vows To Fight Amendments
    24/06/2011: US Patent Reform Advances Furthest In Congress In 10 Years
    22/06/2011: Patent Reform Debate: Live Updates From The US House Of Representatives
    22/06/2011: ‘Long Overdue’ US Patent Reform Deal Reached; House Could Vote This Week
    15/04/2011: Special Report: World’s First IP Financial Exchange To Come Online This Year
    28/01/2011: Innovation, Generic Drugs, Patents In Congress Follow Obama’s State of the Union Speech
    11/01/2011: Patent Reform, Piracy, Generic Drug Issues Likely For US Congress This Year
    11/01/2011: The 2011 Drug Patent ‘Cliff’ And The Evolution Of IP Valuation
    07/11/2010: US FDA’s Tough Road Ahead In Creating Pathway For Life-Saving Biologics
    23/08/2010: US Internet Neutrality Flare-Up Resonates Internationally
    23/06/2010: New US IP Enforcement Plan May Have International Impact
    29/05/2010: US Advisory Group Looks At FCC Net Neutrality Principles As Decision Looms
    10/05/2010: US, WIPO Officials Assess Patent Reform, PCT, Copyright Priorities
    27/01/2010: Global Anti-Counterfeiting Efforts Set To Rise Further
    26/01/2010: 2010 US Industry Group Priorities: Patent Reform, USPTO Funds, Genes, Green Tech
    21/01/2010: Year Ahead: Range Of IP Policy Issues May See Action In United States In 2010
    27/11/2009: UN Talks On IP Licensing And Finance Head To Final Phase
    02/11/2009: UNCITRAL Negotiating IP Finance Draft Text This Week
    05/10/2009: Biotech Legislative Agenda: Healthcare, Energy, Patents And Capital
    24/09/2009: US Acts To Preserve Internet Neutrality; European Debate Heats Up
    31/07/2009: Financial Services, Patent Experts Seek More Certainty On Business-Method Patents, Bilski Case
    27/07/2009: US Biologics Debate Heats Up As Congress, Obama, Wrangle With Healthcare Reform
    18/06/2009: Malgré les obstacles, les pressions de la France au niveau national visant à sanctionner le piratage sur Internet font des émules
    11/06/2009: Copyright Holders Acknowledge Losing Battle For Public Consciousness At World Copyright Summit
    10/06/2009: French Minister Says HADOPI Law A 21st Century Reality
    18/05/2009: US Patent Reform Prospects Unclear; First-To-File Questioned
    Your IP address is 54.196.195.207